ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 529180 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 529180; 2) Community: the network communities that were significantly associated with the response to NSC 529180; 3) Molecule: the relationships between components within communities and NSC 529180; 4) MDR: the compounds that were significantly associated with the NSC 529180.

NSC Compound Enrichment Correlation
NSC 667924 Null 0.00347157511980527 0.079495803
NSC 639539 Null 0.00397405528023196 0.1235465
NSC 642009 Butanedioic acid, 2-[[2-[(3-chloro-1,4-dihydro-1,4-dioxo- 2-naphthalenyl)amino]1,2-dioxo]ethyl]-3-oxo-, dimethyl ester 0.00397405528023196 0.24621683
NSC 268242 N,N-Dibenzyldaunorubicin 0.00457614317494024 0.44587316
NSC 654509 Pirarubicin HCl 0.00457614317494024 0.34582996
NSC 71669 Null 0.00457614317494024 0.25666463
NSC 733503 cis-6-(3-Bromopropyl)-12,13-dihydro-8,9-dimethoxy-3-nitro-5, 11-dioxo-11H-indeno[1,2-c]isoquinoline 0.00457614317494024 0.36251866
NSC 740 Methotrexate 0.00457614317494024 0.38923853
NSC 697747 9H-Quino[4,3,2-de][1,10]phenanthrolin-9-one, 2-(3-methoxyphenyl)- 0.00486817664672767 0.1448127
NSC 240529 2,5-Cyclohexadien-1-one, 4-[[4-[bis(2-chloroethyl)amino]phenyl]imino]-2,6-dimethyl- 0.00501121117465287 0.41512227
Total:45  Current:4    [First] [Prev] [Next] [Last]